Skip to main content
logo
ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,725.00
-20.00 (-0.73%)
At close: Sep 11, 2026

KOSDAQ:034940 Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
61,16259,31162,69462,97468,88057,561
Revenue Growth
1.50%-5.40%-0.45%-8.57%19.66%-11.93%
Gross Profit
22,56621,87421,19923,76126,24220,309
Operating Income
-4,133-6,598-9,828-8,792-482.21-7,003
Net Income
-2,812-6,806-9,605-10,514560.69-8,044
Earnings Per Share
-454.01-1098.42-1550.00-1696.9790.49-1298.21
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,3672,5235,4474,3618,44910,184
Total Debt
26,95227,30524,68917,50118,67816,474
Net Cash (Debt)
-24,585-24,782-19,242-13,141-10,229-6,289
Net Cash Growth
------
Net Cash Per Share
-3969.86-3999.75-3105.27-2120.83-1650.84-1015.09

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1,798-4,180-4,468-1,475-1,443-1,480
Capital Expenditures
-1,061-1,986-551.31-831.13-2,782-3,544
Free Cash Flow
-2,859-6,165-5,019-2,306-4,225-5,024
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
36.90%36.88%33.81%37.73%38.10%35.28%
Operating Margin
-6.76%-11.13%-15.68%-13.96%-0.70%-12.17%
Pretax Margin
-4.11%-10.83%-16.00%-17.36%-0.62%-12.42%
Profit Margin
-4.60%-11.47%-15.32%-16.70%0.81%-13.97%
FCF Margin
-4.67%-10.39%-8.01%-3.66%-6.13%-8.73%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----130.12-
PS Ratio
0.280.530.480.981.062.02